[1]
Z. Fathi and J. . Mohammad, “Adipsin and Leptin as Therapeutic Targets by Dipeptidyl Peptidase-4 Inhibitors in Type 2 Diabetes Mellitus: Review Article”, Iraqi Journal of Pharmaceutical Sciences , vol. 34, no. 4, pp. 1–12, Dec. 2025, doi: 10.31351/vol34iss4pp1-12.